Third primary COVID-19 vaccine dose for people who are immunosuppressed: JCVI advice

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.